Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department
Part of paid clinical trials in The Bronx, New York.
- Sponsor
- Montefiore Medical Center
- Study ID
- NCT07228052
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Dexamethasone 16mg IM — DRUGDexamethasone 16mg Intramuscular Administration Once
- Prednisone 60mg PO — DRUGPrednisone 60mg PO for 5 Days
Study Details
This study aims to compare the efficacy of a one-time IM dose of dexamethasone versus a 5-day course of prednisone in adult ED patients presenting with asthma exacerbations. This is a randomized, controlled, double-blind, non-inferiority trial conducted at two urban EDs within the Montefiore Health System.
Key Dates
- Start date
- Apr 30, 2026
- Status verified
- Mar 2026
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 182 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Single Intramuscular Steroid InjectionDexamethasone 16mg Intramuscular Single Dose
- Active Comparator: Oral Steroid Short CoursePrednisone 60mg PO for 5 Days
Primary Outcome Measure
Asthma Control Test Score [ Time Frame: Within 4 Weeks post-discharge, up to 28-30 days ]
Central Contacts
- Mustfa Manzur, MD MPH MS718-920-6626
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Montefiore Medical Center | The Bronx | New York | 10467 |
Find similar trials in The Bronx, NY
By condition
By specialty
By research site
Related Studies
- Registry of Asthma Characterization and Recruitment 3 (RACR3)Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Aurora, Colorado
- BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled AsthmaRecruiting · Columbia University · Beacon, New York
- A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)PHASE3 · Recruiting · AstraZeneca · Mobile, Alabama
- A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaPHASE3 · Recruiting · GlaxoSmithKline · Birmingham, Alabama